Question 1

What is the catalog number for Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2)?

Accepted Answer

The catalog number for Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2) is A09F22-G-M2.

Question 2

What sizes are available for Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2)?

Accepted Answer

Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2) is available in the following size(s): 1 Each.

Question 3

Is Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2) in stock?

Accepted Answer

Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Human anti-Nipah Virus attachment glycoprotein (G) mAb (M2)

Product Specifications

Type

Analyte

Frequently Asked Questions

Explore Other Products

HLA-DP (MHC II) (HLA-DPB1/2862R), CF740 conjugate, 0.1mg/mL

PLGF (PLGF93), CF640R conjugate, 0.1mg/mL

MUC6 (Mucin 6 / Gastric Mucin) (MUC6/1553R), CF640R conjugate, 0.1mg/mL

CD21 (Mature B-Cell & Follicular Dendritic Cell Marker) (CR2/1952), 1mg/mL

HPV-16 (Human Papilloma Virus 16) (HPV16/1295), CF488A conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), CF568 conjugate, 0.1mg/mL